News
Scope BioSciences Secures €2.5 Million EIC-Transition Grant
Wageningen, The Netherlands – Venture Challenge alumnus Scope Biosciences announces the award of a €2.5 million EIC Transition grant, a testament to its groundbreaking work in molecular diagnostics.
Operating with VR: 'Erasmus MC Can't Do Without'
Translated from Dutch Original author: Thijs Baas
Sirius Medical Celebrates the Enrollment of the First Patient in the MELODY Study with Pintuition®
Eindhoven, Netherlands – Sirius Medical is proud to celebrate the enrollment of the first patient in the MELODY Study using the innovative Sirius Pintuition System by Prof. Dr. Banys-Paluchowski.
Apply now for the Venture Challenge Spring 2024
On 1 January 2024 a new application round of the Venture Challenge has opened.
RIBOPRO Secures €1.9 Million in Convertible Loan, Accelerating Progress in mRNA Technology and Series A Funding
Oss, Netherlands, January 10, 2024 — RIBOPRO, a leading biotechnology company specializing in supporting biotech and bio-pharma through the co-creation of innovative mRNA drugs based on patented mRNA technologies and high-quality mRNA/LNP producti
NutriLeads Completes 4.5 Million Euro Series C Financing to Accelerate Commercialization of BeniCaros as a Global Precision Prebiotic Brand
Company also announces Board and Management changes and new scientific advisory board December 18, 2023 – NutriLeads BV today announced that it has raised 4.5 million euros in a Series C investment round to accelerate the commercializatio
Predica Diagnostics wins Investor Forum
Today, at the Dutch Life Sciences Conference in Corpus, Venture Challenge alumnus Predica Diagnostics was selected winner of the Investor Forum.
XS-Innovations wins Venture Challenge Fall 2023!
The winner of the Venture Challenge was announced today at the Dutch Life Sciences Conference. The proud winner of the 2023 fall edition is
€1.4 million for the acceleration of VivArt-X research
Venture Challenge alumnus VivArt-X will collaborate with Smart BioMaterials Consortium (SBMC) and
Venture Challenge Spring 2023 winner Exculture has successfully secured €350,000 in financing from UNIIQ/Delft Enterprises.
ExCulture is working on the development of a fermentation process that has the potential to provide a safer way of producing heparin on a larger scale.